Aptila Biotech
PrivateLast Round
Seed
Mar 25, 2025
Company Overview
Aptila Biotech operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Seed round in March 2025.
Aptila Biotech GmbH is a biotechnology company that develops AI-powered software for processing mass spectrometry proteomics data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Healthcare Analytics, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptila Biotech Comparables
Compare Aptila Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MSAID GmbH | 84% | |
| Bioinformatics Solutions Inc. | 77% | |
| Matrix Science | 76% |
For institutional investors. Book with your work email.
Aptila Biotech Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Aptila Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascenion | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 608% MoM.
- Apr 5, 2026
Monthly visitors grew 142% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
Aptila Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aptila Biotech's valuation, stock price, and market status.
Is Aptila Biotech a public or private company?
Aptila Biotech is a private company.
What is the current stock price of Aptila Biotech?
Aptila Biotech is a private company, so its shares have no public market price. Caplight tracks Aptila Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aptila Biotech worth (valuation)?
Valuation information for Aptila Biotech is not publicly available.
Can I buy Aptila Biotech stock?
Aptila Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aptila Biotech's last funding round?
Aptila Biotech's most recent funding round was Seed on March 25, 2025.
Who are the main investors in Aptila Biotech?
Key investors in Aptila Biotech include Ascenion.
Will Aptila Biotech IPO soon?
No public IPO plans have been announced for Aptila Biotech.
How can I track Aptila Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Aptila Biotech's shares on secondary markets.